Schedule 13D ownership disclosure

N/A

Common Stock, par value $0.0001 per share · CUSIP: 78667J108

Event date: 2025-01-10

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOGEN INC.Reported CIK 0000875045

    Shares: 6,241,473 · Class: 10.2%

  • Biogen MA Inc.

    Shares: 6,241,473 · Class: 10.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-004311
Form type
SCHEDULE 13D
Filer
BIOGEN INC.
CIK
CIK 875045
Filed
Jan 10, 2025
Reporting period
Jan 10, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub